-
EP3932908
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3932908
| EP3932908 - SUBSTITUTED PYRAZOLE COMPOUNDS, COMPOSITIONS CONTAINING SAME, AND USE THEREOF [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 03.12.2021 Database last updated on 28.05.2024 | |
| Former | The international publication has been made Status updated on 04.09.2020 | Most recent event Tooltip | 29.01.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Shenzhen TargetRx, Inc. Room 301 Unit 1 Building A Kexing Science Park No.15 of Keyuan Road Nanshan District Shenzhen, Guangdong 518057 / CN | [2022/01] | Inventor(s) | 01 /
WANG, Yihan Room 301, Building A1 Kexing Science Park, No.15 Of Keyuan Road, Nanshan District Shenzhen, Guangdong 518057 / CN | 02 /
REN, Xingye Room 301, Building A1 Kexing Science Park, No.15 Of Keyuan Road, Nanshan District Shenzhen, Guangdong 518057 / CN | [N/P] |
| Former [2022/01] | 01 /
WANG, Yihan Shenzhen, Guangdong 518057 / CN | ||
| 02 /
REN, Xingye Shenzhen, Guangdong 518057 / CN | Representative(s) | Freyria Fava, Cristina Buzzi, Notaro & Antonielli d'Oulx S.p.A. Corso Vittorio Emanuele ll, 6 10123 Torino / IT | [2022/01] | Application number, filing date | 20763417.1 | 26.02.2020 | [2022/01] | WO2020CN76756 | Priority number, date | CN201910145179 | 27.02.2019 Original published format: CN201910145179 | [2022/01] | Filing language | ZH | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020173457 | Date: | 03.09.2020 | Language: | ZH | [2020/36] | Type: | A1 Application with search report | No.: | EP3932908 | Date: | 05.01.2022 | Language: | EN | [2022/01] | Search report(s) | International search report - published on: | CN | 03.09.2020 | (Supplementary) European search report - dispatched on: | EP | 17.10.2022 | Classification | IPC: | C07D231/14, A61K31/4155, A61P35/00 | [2022/01] | CPC: |
A61P5/28 (EP,CN);
C07D231/14 (EP,CN,US);
A61P35/00 (EP,CN);
C07D231/12 (US);
C07B2200/05 (CN,US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/01] | Title | German: | SUBSTITUIERTE PYRAZOLVERBINDUNGEN, DIESE ENTHALTENDE ZUSAMMENSETZUNGEN UND DEREN VERWENDUNG | [2022/01] | English: | SUBSTITUTED PYRAZOLE COMPOUNDS, COMPOSITIONS CONTAINING SAME, AND USE THEREOF | [2022/01] | French: | COMPOSÉS DE PYRAZOLE SUBSTITUÉS, COMPOSITIONS LES CONTENANT ET UTILISATION ASSOCIÉE | [2022/01] | Entry into regional phase | 16.09.2021 | Translation filed | 16.09.2021 | National basic fee paid | 16.09.2021 | Search fee paid | 16.09.2021 | Designation fee(s) paid | 16.09.2021 | Examination fee paid | Examination procedure | 16.09.2021 | Examination requested [2022/01] | 28.03.2023 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 15.02.2022 | Renewal fee patent year 03 | 15.02.2023 | Renewal fee patent year 04 | 29.01.2024 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO2011051540 (ORION CORP [FI], et al) [X] 1-12 * examples 56, 207, 229, 245, 300, 318; claims 1, 8 *; | [A] - "Precision Deuterium Chemistry Backgrounder - Non-Confidential", INTERNET CITATION, (20070101), pages 1 - 6, URL: http://www.concertpharma.com/about/documents/ConcertProductPlatformBackgrounder.pdf, XP002687117 [A] 1-12 * page 2 - page 3 * | International search | [X]CN102596910 (ORION CORP) [X] 1-11, 13 (partially)* see claims 1-11, description, paragraph 0121, and embodiments 56, 207, 229, 245, 300, and 318 * | by applicant | US5376645 | - "Prodrugs as Novel Delivery Systems", T. HIGUCHIV. STELLA, A.C.S. Symposium Series, American Pharmaceutical Association and Pergamon Press, (19870000), vol. 14 | - D. FLEISHERS. RAMONH. BARBRA, "Improved oral drug delivery: solubility limitations overcome by the use of prodrugs", Advanced Drug Delivery Reviews, (19960000), vol. 19, no. 2, pages 115 - 130 |